Pentwater Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-761,700
Closed -$15.8M 95
2017
Q4
$15.8M Hold
761,700
0.11% 56
2017
Q3
$10.9M Sell
761,700
-143,200
-16% -$2.17M 0.09% 62
2017
Q2
$15.7M Sell
904,900
-40,000
-4% -$479K 0.14% 52
2017
Q1
$10.4M Sell
944,900
-2,825,400
-75% -$38.9M 0.13% 50
2016
Q4
$54.7M Hold
3,770,300
0.7% 29
2016
Q3
$92.6M Hold
3,770,300
0.86% 20
2016
Q2
$75.9M Buy
3,770,300
+1,350,500
+56% +$38.2M 1.01% 24
2016
Q1
$63.6M Buy
2,419,800
+2,189,800
+952% +$162M 0.47% 32
2015
Q4
$23.4M Buy
+230,000
New +$25.8M 0.16% 52
2014
Q4
Sell
-220,000
Closed -$28.9M 153
2014
Q3
$28.9M Sell
220,000
-100,000
-31% -$11.9M 0.28% 59
2014
Q2
$40.4M Buy
+320,000
New +$40.8M 0.43% 39

Other funds holding BHC

Pentwater Capital Management's BHC Position: Q1 2018 in Review

Pentwater Capital Management sold out of Bausch Health (BHC) in Q1 2018, closing a stake of 761,700 shares — an estimated $15.8M sold.

Pentwater Capital Management first reported a position in BHC in Q2 2014 and held it in 12 quarters. The position peaked at $205M in Q3 2014. 327 funds tracked by Wall St. Rank hold BHC as of Q1 2018.

  • Pentwater Capital Management reported no remaining Bausch Health position as of Q1 2018 after selling out during the quarter.
  • Pentwater Capital Management sold 761,700 Bausch Health shares in Q1 2018, an estimated $15.8M.
  • Pentwater Capital Management first reported a position in Bausch Health in Q2 2014 and held it in 12 quarters.
  • Pentwater Capital Management's Bausch Health position peaked at $205M in Q3 2014.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q1 2018.

Based on Pentwater Capital Management's 13F filing for Q1 2018, filed 15 May 2018.